Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Research In Brief

This article was originally published in The Gray Sheet

Executive Summary

NEJM's impact on vertebroplasty: Vertebroplasty and vertebral augmentation procedures have declined 10% since studies published in the August New England Journal of Medicine found the procedures had no lasting benefit, according to a Millennium Research Group report. The report, based on a survey of 245 U.S. physicians, said the decrease in procedures was largely due to fewer patient referrals. MRG notes that 70% of specialists who perform vertebroplasty compression fracture (VCF) treatments disagree with the NEJM findings, versus 30% of referring physicians. In the blinded, randomized, placebo-controlled studies, the treatment showed no significant difference in the primary endpoint of overall pain up to six months post-procedure (1"The Gray Sheet" Aug. 10, 2009)

You may also be interested in...

Vertebroplasty Shows No More Benefit Than Sham Procedures In Trials

The first two blinded, randomized, placebo-controlled trials of vertebroplasty treatment for spinal fractures suggest that the procedure may have no lasting benefit, researchers report in the Aug. 6 New England Journal of Medicine

QUOTED. 6 April 2020. Bethany Hills.

Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.

Health And Wellness Trademark Review 31 March, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts